James Noble Insider Trading
Get free email notifications about insider trading for James Noble.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Noble. James Noble is a Director in CURAGEN CORP ($CRGN) and a Director in GW PHARMACEUTICALS PLC ($GWPH) and an Chief Executive Officer in Adaptimmune Therapeutics PLC ($ADAP) and a Director in Adaptimmune Therapeutics PLC ($ADAP).
Address: 322 EAST MAIN STREET BRANFORD 06405 CT
Companies in which James Noble is an Insider
Adaptimmune Therapeutics PLC
Trading Symbol: ADAPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James Noble: Director, Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CURAGEN CORP
Trading Symbol: CRGNIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of James Noble: Director
Holdings: 0 shares
Latest Transaction: Oct 05 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GW PHARMACEUTICALS PLC
Trading Symbol: GWPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James Noble: Director
Holdings: 41,979 shares
Latest Transaction: Feb 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James Noble
Sentiment: All, ADAP, CRGN, GWPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2021 | GWPH | GW PHARMACEUTICALS ... | Noble James | Director | Option Exercise | A | 0.00 | 22,464 | 31 | 22,464 | |
Jul 01 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Option Exercise | A | 1.67 | 179,785 | 300,241 | 179,785 | |
Jun 08 2020 | GWPH | GW PHARMACEUTICALS ... | Noble James | Director | Option Exercise | A | 0.00 | 34,416 | 45 | 34,416 | |
Jun 02 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Sell | S | 9.33 | 500,000 | 4,666,000 | 0 | 500 K to 0 (-100.00 %) |
Apr 01 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Option Exercise | A | 0.45 | 31,000 | 13,950 | 31,000 | |
Jan 15 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Sell | S | 5.00 | 200,000 | 1,000,000 | 0 | 200 K to 0 (-100.00 %) |
Jan 15 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Sell | S | 4.00 | 100,000 | 400,000 | 0 | 100 K to 0 (-100.00 %) |